235 related articles for article (PubMed ID: 16596462)
1. Treatment of osteoporosis with TheraCyte-encapsulated parathyroid cells: a study in a rat model.
Chou FF; Huang SC; Chen SS; Wang PW; Huang PH; Lu KY
Osteoporos Int; 2006; 17(6):936-41. PubMed ID: 16596462
[TBL] [Abstract][Full Text] [Related]
2. Effect of TheraCyte-encapsulated parathyroid cells on lumbar fusion in a rat model.
Chen SH; Huang SC; Lui CC; Lin TP; Chou FF; Ko JY
Eur Spine J; 2012 Sep; 21(9):1734-9. PubMed ID: 22766833
[TBL] [Abstract][Full Text] [Related]
3. [The replacement therapy of rPTH(1-84) in established rat model of hypothyroidism].
Ding Z; Li T; Liu Y; Xiao S
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Dec; 50(12):1020-5. PubMed ID: 26888134
[TBL] [Abstract][Full Text] [Related]
4. The use of simvastatin with aromasin in an ovariectomized rat model: effects on the skeletal system.
Chen SH; Chou FF; Ko JY
Chang Gung Med J; 2010; 33(5):509-14. PubMed ID: 20979701
[TBL] [Abstract][Full Text] [Related]
5. Parathyroidectomy can improve bone mineral density in patients with symptomatic secondary hyperparathyroidism.
Chou FF; Chen JB; Lee CH; Chen SH; Sheen-Chen SM
Arch Surg; 2001 Sep; 136(9):1064-8. PubMed ID: 11529832
[TBL] [Abstract][Full Text] [Related]
6. [Experimental study on effect of anhydroicaritin phytosomes in preventing and treating bone loss and enhancing bone quality in ovariectomized osteoporosis rats].
Wu MS; Zhao SZ; Ren LZ; Wang R; Bai X; Han HW; Li B
Zhongguo Zhong Yao Za Zhi; 2013 Jul; 38(13):2163-8. PubMed ID: 24079247
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin enhances bone density in ovariectomized rats given 17beta-estradiol or human parathyroid hormone(1-34).
Kawane T; Terashima S; Kurahashi I; Yanagawa T; Yoshida H; Horiuchi N
Endocrine; 2004 Jul; 24(2):121-9. PubMed ID: 15347837
[TBL] [Abstract][Full Text] [Related]
8. Effects of treatment with parathyroid hormone 1-84 on quantity and biomechanical properties of thoracic vertebral trabecular bone in ovariectomized rhesus monkeys.
Fox J; Newman MK; Turner CH; Guldberg RE; Varela A; Smith SY
Calcif Tissue Int; 2008 Mar; 82(3):212-20. PubMed ID: 18297227
[TBL] [Abstract][Full Text] [Related]
9. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
[TBL] [Abstract][Full Text] [Related]
10. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
Shen V; Birchman R; Wu DD; Lindsay R
J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
[TBL] [Abstract][Full Text] [Related]
11. [Effect of total flavones of Epimedium leptorrhizum on osteoporosis in ovariectomized rats].
Cao CY; Liu T; Hui LQ; Hao R
Zhongguo Zhong Yao Za Zhi; 2014 May; 39(10):1913-7. PubMed ID: 25282905
[TBL] [Abstract][Full Text] [Related]
12. Long-term changes in bone mineral and biomechanical properties of vertebrae and femur in aging, dietary calcium restricted, and/or estrogen-deprived/-replaced rats.
Jiang Y; Zhao J; Genant HK; Dequeker J; Geusens P
J Bone Miner Res; 1997 May; 12(5):820-31. PubMed ID: 9144349
[TBL] [Abstract][Full Text] [Related]
13. Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial.
Lane NE; Sanchez S; Modin GW; Genant HK; Pierini E; Arnaud CD
J Bone Miner Res; 2000 May; 15(5):944-51. PubMed ID: 10804025
[TBL] [Abstract][Full Text] [Related]
14. [Effects of salmon calcitonin in treatment of osteoporosis in patients undergoing dialysis].
Wang SX; Li H
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):387-90. PubMed ID: 18581891
[TBL] [Abstract][Full Text] [Related]
15. Salmon calcitonin in prevention of osteoporosis in maintenance dialysis patients.
Wang SX; Li H
Chin Med J (Engl); 2008 Jul; 121(14):1280-4. PubMed ID: 18713548
[TBL] [Abstract][Full Text] [Related]
16. Time-course of vertebral and femoral bone loss in rats administered gonadotrophin-releasing hormone agonist.
Kurabayashi T; Fujimaki T; Yasuda M; Yamamoto Y; Tanaka K
J Endocrinol; 1993 Jul; 138(1):115-25. PubMed ID: 7852882
[TBL] [Abstract][Full Text] [Related]
17. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis.
Finkelstein JS; Hayes A; Hunzelman JL; Wyland JJ; Lee H; Neer RM
N Engl J Med; 2003 Sep; 349(13):1216-26. PubMed ID: 14500805
[TBL] [Abstract][Full Text] [Related]
18. Effects of alendronate on bone mineral density and bone metabolic markers in patients with liver transplantation.
Atamaz F; Hepguler S; Akyildiz M; Karasu Z; Kilic M
Osteoporos Int; 2006; 17(6):942-9. PubMed ID: 16550299
[TBL] [Abstract][Full Text] [Related]
19. [Effect of estrogen on the expression of matrix GLA protein in ovariectomized SD rats].
Chen XY; Jiang XH; Lai XY; Fang XN; Yang Y
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):833-8. PubMed ID: 23302124
[TBL] [Abstract][Full Text] [Related]
20. Effects of human parathyroid hormone 1-34 on bone loss and lumbar intervertebral disc degeneration in ovariectomized rats.
Luo Y; Li SY; Tian FM; Song HP; Zhang YZ; Zhang L
Int Orthop; 2018 May; 42(5):1183-1190. PubMed ID: 29442158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
